Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.67 |
| ▸ | CA2 | P00918 | 7/20 | 0.67 |
| ▸ | CA9 | Q16790 | 5/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 4/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.48 |
| ▸ | CA4 | P22748 | 3/20 | 0.48 |
| ▸ | CA6 | P23280 | 3/20 | 0.48 |
| ▸ | CA5A | P35218 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL3198737 | 0.98 | CA1 (0.65) | CA1CA2CA9HTTALDH1A1 | |
| Hydrazine SCHEMBL28200768 | 0.96 | CA1 (0.68) | CA1CA2CA9HTTALDH1A1 | |
| SCHEMBL866410 | 0.83 | CA1 (0.71) | CA1CA2CA9HTTALDH1A1 | |
| Sulfuric Acid SCHEMBL28654341 | 0.80 | CA1 (0.62) | CA1CA2CA9ALDH1A1CA12 | |
| SCHEMBL22832592 | 0.80 | HTR2A (0.66) | CA1CA2CA9HTTALDH1A1 | |
| SCHEMBL8690274 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTALDH1A1 | |
| SCHEMBL3519559 | 0.80 | CA2 (1.00) | CA1CA2CA9HTTCA12 | |
| SCHEMBL4826239 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTALDH1A1 | |
| Potassium Ion SCHEMBL1902294 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTALDH1A1 | |
| SCHEMBL17318171 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 459 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290051-A1 | MUTATED SULFOTRANSFERASES AND USES THEREOF | SANOFI SA (FR) | 2025-09-18 | — | — | US | claimed |
| US-20250012802-A1 | SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA | FOLLEA INTERNATIONAL | 2025-01-09 | — | — | US | claimed |
| EP-4488388-A1 | SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA | Follea International (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119265294-A | Methods and systems for predicting the response of oral minoxidil to treatment of androgenic alopecia | 芙丽亚国际公司 | 2025-01-07 | — | — | CN | claimed |
| EP-4408988-A1 | USES AND METHODS FOR SULFATING A SUBSTRATE WITH A MUTATED ARYLSULFOTRANSFERASE | Sanofi (FR) | 2024-08-07 | — | — | EP | claimed |
| CN-118339282-A | Use and method of sulfating a substrate with a mutated arylsulftransferase | 赛诺菲 | 2024-07-12 | — | — | CN | claimed |
| US-20240093166-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | GINKGO BIOWORKS, INC. | 2024-03-21 | — | — | US | claimed |
| US-20240076634-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | GINKGO BIOWORKS, INC. | 2024-03-07 | — | — | US | claimed |
| US-20240002819-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | GINKGO BIOWORKS, INC. | 2024-01-04 | — | — | US | claimed |
| US-20230340552-A1 | METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES | GINKGO BIOWORKS, INC. | 2023-10-26 | — | — | US | claimed |
| WO-2008079469-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-20080070231-A1 | Reporter genes taken up by microorganism, and repressor gene inhibits expression | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20080070272-A1 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20050255562-A1 | Methods for synthesis of sulfated saccharides | NATIONAL INSTITUTES OF HEALTH | 2005-11-17 | — | — | US | claimed |
| US-6255088-B1 | Enzymatic sulfation of biomolecules | THE SCRIPPS RESEARCH INSTITUTE | 2001-07-03 | — | — | US | claimed |
| US-6225100-B1 | ENZYME FROM CLOSTRIDIUM WITH STORAGE AND REACTION STABILITY; FOR EFFICIENT SULFATION OF TYROSYLPEPTIDES SUCH AS CHOLECYSTOKININ | DCV, INC. | 2001-05-01 | — | — | US | claimed |
| WO-1998003636-A9 | NOVEL ARYLSULFOTRANSFERASE | — | 1998-05-22 | — | — | WO | claimed |
| WO-1998003636-A1 | NOVEL ARYLSULFOTRANSFERASE | BIO-TECHNICAL RESOURCES (US) | 1998-01-29 | — | — | WO | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| US-5270196-A | Arylsulfatase from streptomyces | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-12-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340552-A1 | METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES | CSGALNACT1, NANS, STS | CA1 1261/4885CA2 1650/4885CA9 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.